GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today shared the results of a study ...

This article first appeared on GuruFocus. Inogen Inc (NASDAQ:INGN) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $92.20 million, and the earnings ...

Home care oxygen therapy provider Inogen Inc ( INGN) is expanding its manufacturing capacity. The company recently agreed to lease approximately 23,890 square feet area in Richardson, TX, which will ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results ...

As the U.S. healthcare system continues to grapple with rising costs, an aging population, workforce shortages, and pressure ...

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

Inogen has continued to struggle, with growth in the rental business overshadowed by declines in direct-to-consumer sales, volatility in business-to-business sales, and pricing pressures. Inogen has ...